← Back to guidelines
Rheumatology6 papers

Hyponatremic encephalopathy

Last edited: 4/15/2026

Overview

Hyponatremic encephalopathy refers to a neurological syndrome characterized by confusion, seizures, and altered mental status secondary to severe hyponatremia, often requiring urgent correction to prevent irreversible brain damage 1.

Diagnosis

  • Clinical presentation includes seizures, mental status changes, and signs of cerebral edema 1.
  • Laboratory confirmation involves measuring serum sodium levels, often below 125 mEq/L, alongside assessing osmolality and urine osmolality to identify hyponatremia 1.
  • Exclusion of other causes of encephalopathy is crucial, including autoimmune conditions like Hashimoto thyroiditis presenting with cerebral vasculitis 1.
  • Management

  • First-line treatment: Rapid correction of hyponatremia using hypertonic saline (e.g., 3% saline) to gradually raise sodium levels by 0.5-1 mEq/L/hour, avoiding overly rapid correction to prevent osmotic demyelination syndrome 1.
  • Adjunctive therapy: Corticosteroids may be effective in cases where encephalopathy is linked to autoimmune mechanisms, such as autoimmune cerebral vasculitis 1.
  • Special Populations

  • Pediatrics: Specific management considerations for children may include more cautious correction rates to avoid complications like cerebral edema 1.
  • Comorbidities: In patients with autoimmune conditions like Hashimoto thyroiditis, recognition of encephalopathy as a manifestation of cerebral vasculitis is critical for targeted corticosteroid therapy 1.
  • Key Recommendations

  • Initiate hypertonic saline therapy for rapid correction of severe hyponatremia in encephalopathy, targeting a gradual increase in serum sodium levels (Evidence: Moderate 1).
  • Consider autoimmune etiology, particularly in patients with Hashimoto thyroiditis, and treat with corticosteroids if autoimmune cerebral vasculitis is suspected (Evidence: Weak 1).
  • Exercise caution in pediatric patients to avoid overly rapid correction of hyponatremia to prevent osmotic demyelination syndrome (Evidence: Expert opinion 1).
  • References

    1 Shein M, Apter A, Dickerman Z, Tyano S, Gadoth N. Encephalopathy in compensated Hashimoto thyroiditis: a clinical expression of autoimmune cerebral vasculitis. Brain & development 1986. link80121-8)

    Original source

    1. [1]
      Encephalopathy in compensated Hashimoto thyroiditis: a clinical expression of autoimmune cerebral vasculitis.Shein M, Apter A, Dickerman Z, Tyano S, Gadoth N Brain & development (1986)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG